- Advertisement -
- Advertisement -

Swedish Hedge Funds Among Institutional Investors in Immunicum Directed Share Issue

- Advertisement -

Stockholm (HedgeNordic) – Immunicum, a Swedish company said to be creating the blue print for the world’s first personalized, off-the-shelf affordable cancer treatment, has decided to implement a directed issue of approximately SEK 178 million and a rights issue of approximately SEK 173 million, according to a press release.

The money to be raised is aimed at continuing to finance the clinical development of the company´s immunotherapeutical drug ilixadencel.

Several institutions are among the investors subscribing to the directed issue including three Swedish hedge fund companies; Gladiator, Nordic Cross, and Adrigo. Other institutions include AP2, AP4, and Alfred Berg.

Photo by Louis Reed on Unsplash.

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

HedgeNordic Editorial Team
HedgeNordic Editorial Team
This article was written, or published, by the HedgeNordic editorial team.

Latest Articles

The ART of Finding Right Tails

Stockholm (HedgeNordic) – Philosopher Nassim Nicholas Taleb coined the term ‘Black Swan’ to describe the tendency to underestimate the likelihood of extreme, hard-to-predict events,...

Cevian Acquires Stake in Swiss Insurer

Stockholm (HedgeNordic) – Swedish activist investor Cevian Capital has unveiled a 3.12 percent stake in Swiss insurer Baloise Holding AG. The stake is valued...

Nordic Hedge Funds Sustain Momentum

Stockholm (HedgeNordic) – Following its strongest first quarter in 15 years, the Nordic hedge fund industry sustained momentum into April. As reflected by the...

The Hands-On Approach of NCI Advisory in Debt Investing

Stockholm (HedgeNordic) – With over 45 years of expertise in structured finance and debt asset management, Jørgen Beuchert has dedicated the last 15 years...

Hedge Fund Journal: Calculo Best in Commodity Trend Following

Stockholm (HedgeNordic) – Calculo Evolution Fund, a pure commodity trend-follower based in Denmark, has been recognized as the “Best Performing Commodity Trend Follower” over...

SRV’s Multi-Pillar Fixed-Income Strategy

Stockholm (HedgeNordic) – Despite Danish mortgage bonds being widely regarded as almost risk-free, occasional spikes in risk aversion trigger significant spread widening versus government...

Allocator Interviews

Latest Articles

In-Depth: High Yield

Voices

Request for Proposal

- Advertisement -